Med Consumer Watch
Mounjaro and Thyroid Cancer: Understanding the Risk
Back to Articles
Safety10 min readApril 7, 2026

Mounjaro and Thyroid Cancer: Understanding the Risk

A detailed look at the thyroid cancer warning on Mounjaro. What the studies show and how to make informed decisions.

By Med Consumer Watch Team
Mounjaro carries a black box warning about thyroid C-cell tumors. Understanding this warning helps you make informed decisions about treatment.

Why the Warning Exists

The background: • GLP-1 receptor agonists caused thyroid tumors in rodent studies • Rats and mice developed medullary thyroid carcinoma (MTC) • Effect was dose and duration dependent • FDA requires this warning on all GLP-1 medications

Rodent vs Human Differences

Important biological distinctions: • Rodents have many more GLP-1 receptors on thyroid C-cells • Human thyroid C-cells have minimal GLP-1 receptor expression • The mechanism may not apply to humans • Over a decade of GLP-1 use hasn't shown increased MTC rates in humans

Many medications that cause problems in rodent studies don't cause the same issues in humans due to biological differences.

Who Should Not Take Mounjaro

Absolute contraindications:
  • Personal history of medullary thyroid carcinoma
  • Family history of MTC in first-degree relatives
  • Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

If you have any family history of thyroid cancer, discuss the specific type with your doctor before starting treatment.

Symptoms to Monitor

Watch for and report: • A lump or swelling in your neck • Hoarseness or voice changes • Trouble swallowing • Shortness of breath These could indicate thyroid problems requiring evaluation.

Putting Risk in Perspective

Context matters: • MTC is very rare (about 3% of thyroid cancers) • No causal link established in humans after years of GLP-1 use • The warning is precautionary based on animal data • Benefits of treatment may outweigh theoretical risks for most people • Discuss your individual risk factors with your doctor

The Bottom Line

The thyroid cancer warning on Mounjaro reflects rodent study findings that haven't been replicated in humans. For most people without personal or family history of MTC or MEN 2, the theoretical risk is considered very low. However, always disclose your complete medical and family history and report any thyroid-related symptoms promptly.

Sources & References

  • FDA - Mounjaro Prescribing Information
  • Thyroid - GLP-1 Receptor Agonists and Thyroid Cancer

Medical Disclaimer

This article is for informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare provider before making decisions about your health or medications. Individual experiences may vary.

Related Articles

Has Anyone Gotten Thyroid Cancer From Mounjaro?

Read more

Does Mounjaro Cause Cancer?

Read more
Back to All Articles

Enter to Win a $1,788 CoreAge Rx Gift Card

Enter for a chance to use it toward eligible CoreAge Rx products and services.

The gift card may be applied toward eligible CoreAge Rx products and services. Prescription products additionally require completing the intake process and evaluation by a licensed healthcare provider, who alone decides eligibility and treatment. Winning does not guarantee that you will qualify for a GLP-1 medication or any other prescription treatment.

No purchase necessary. Prescription products require provider evaluation and approval. See Official Rules. Official Rules · Gift Card Terms · Privacy Policy · Terms